Lotus Health Group Co
SSE:600186
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Lotus Health Group Co
Pre-Tax Income
Lotus Health Group Co
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Lotus Health Group Co
SSE:600186
|
Pre-Tax Income
¥396m
|
CAGR 3-Years
79%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Pre-Tax Income
¥9.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Pre-Tax Income
¥8.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Pre-Tax Income
¥3.7B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Pre-Tax Income
¥10.1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
26%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Pre-Tax Income
¥2.4B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-12%
|
|
Lotus Health Group Co
Glance View
Nestled in China's burgeoning pharmaceutical and healthcare industry, Lotus Health Group Co. stands as a significant player primarily in the production and distribution of monosodium glutamate (MSG) and other nutritional health products. Lotus Health leverages its extensive network and cutting-edge production facilities to churn out substantial volumes of MSG and mixed condiments, fulfilling both domestic and international demands. The company has strategically positioned itself in the health and wellness sectors, capitalizing on the global trend toward improved dietary habits and a growing focus on nutritional enhancement. By maintaining strict quality controls and optimizing their production processes, Lotus Health can offer competitive pricing, which forms the linchpin of their business success. The company doesn't just stop at producing MSG — its portfolio extends into glucose and starch products, used widely in food and industrial applications. Lotus Health cleverly navigates the intricate balance of catering to the food industry's demands while progressively innovating in the health product space. With a firm grasp on supply chain efficiencies and a keen eye for market trends, Lotus Health continues to monetize its operations through economies of scale and product diversification. Through these efforts, the company bolsters its growth trajectory, positioning itself to take advantage of the shifts in global dietary patterns and the broadening acceptance of MSG.
See Also
What is Lotus Health Group Co's Pre-Tax Income?
Pre-Tax Income
396m
CNY
Based on the financial report for Sep 30, 2025, Lotus Health Group Co's Pre-Tax Income amounts to 396m CNY.
What is Lotus Health Group Co's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
52%
Over the last year, the Pre-Tax Income growth was 47%. The average annual Pre-Tax Income growth rates for Lotus Health Group Co have been 79% over the past three years , 52% over the past five years .